In the BioHarmony Drug Report Database

"Preview" Icon

Eliglustat

Cerdelga (eliglustat) is a small molecule pharmaceutical. Eliglustat was first approved as Cerdelga on 2014-08-19. It is used to treat gaucher disease in the USA. It has been approved in Europe to treat gaucher disease. Cerdelga’s patents are valid until 2038-12-13 (FDA).

 

Trade Name

 

Cerdelga
 

Common Name

 

eliglustat
 

ChEMBL ID

 

CHEMBL2110588
 

Indication

 

gaucher disease
 

Drug Class

 

Enzyme inhibitors: glucosyltransferase inhibitors

Image (chem structure or protein)

Eliglustat structure rendering